Health Care: Drugs

Targacept Inc (TRGT: NASDAQ)

$2.4299 0.0699 | 2.96%
08/04/15 - 11:39 AM ET
Company Profile
Price and Volume
Recent Price 2.36
52 Week High 3.23
52 Week Low 2.15
Avg. Daily Vol. (Mil) 0.07
Beta (3 year) 1.41
Share Related Items
Mkt Cap (Mil) 79.94
Shares Out (Mil) 33.87
Float (Mil) 22.71
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 26.90
Current Ratio 27.00
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 322.33
Price/Book 0.77
Price/Cash Flow -3.40
Per Share Data
Earnings -0.72
Sales 0.01
Book Value 3.05
Cash Flow -0.69
Business Summary
Targacept Inc is a biopharmaceutical company. It is engaged in the design, discovery and development of NNR Therapeutics to treat patients suffering from nervous system and gastrointestinal/genitourinary diseases and disorders.
General Information
100 North Main Street
Suite 1510
Winston-Salem, NC 27101
www.targacept.com
Industry : Drugs
Sector: Health Care
Employees: 19
CEO: Stephen A. Hill,B.M.
Short Interest
Current Month (Mil) 0.12
Previous Month (Mil) 0.14
Short Interest Ratio (Days) 1.70
Management Effectiveness
Return on Equity n.a.
Return on Assets -22.80
Return on Investments -23.60
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with TRGT

Latest TRGT Headlines from TheStreet

More Financial News for TRGT

Press Releases for TRGT

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter